Iowa HF320 amends the right to try Act to expand eligibility for investigational treatments and clarify patient responsibilities.

Iowa HF320 modifies the right to try Act by expanding the definition of an "eligible patient" to include those with life-threatening or severely debilitating illnesses, in addition to terminal illnesses. It also introduces the concept of "individualized investigational treatment," which is a drug, biological product, or device tailored to an individual patient's genetic profile. The bill ensures that patients are informed about the potential risks and outcomes of using these treatments and clarifies that patients are liable for all expenses related to the investigational treatment.

Iowa HF320 amends the right to try Act to expand eligibility for investigational treatments and clarify patient responsibilities.

Iowa HF320 modifies the right to try Act by expanding the definition of an "eligible patient" to include those with life-threatening or severely debilitating illnesses, in addition to terminal illnesses. It also introduces the concept of "individualized investigational treatment," which is a drug, biological product, or device tailored to an individual patient's genetic profile. The bill ensures that patients are informed about the potential risks and outcomes of using these treatments and clarifies that patients are liable for all expenses related to the investigational treatment.